SPRINT BIOSCIENCE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.26 SEK | +0.64% |
|
+3.96% | -27.38% |
| 05-08 | Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-14 | Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRINT BIOSCIENCE AB | Bio Therapeutic Drugs | +0.64% | +3.96% | -27.38% | +113.56% | -92.61% | 8.39M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SPRINT Stock
- Charts Sprint Bioscience AB
- Comparison Chart